Literature DB >> 11870805

Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities.

Yutaka Kubota1, Kazuto Ito, Kyoichi Imai, Hidetoshi Yamanaka.   

Abstract

BACKGROUND: A study was conducted to investigate the effectiveness of mass screening (MS) for prostate cancer in Japanese communities using the long-term follow-up results.
METHODS: Subjects were 279 patients with prostate cancer detected by MS in Gunma prefecture (MS group) and 624 patients with prostate cancer who did not undergo screening (non-MS group). From the follow-up data, the prognoses were compared between the groups.
RESULTS: The ratio of patients with Stage II cancer was higher for the MS group (59.1%) when compared to non-MS group (25.3%). As a whole, the prognosis of the MS group was more favorable than that of the non-MS group for relative survival rate. Prognosis was especially favorable for patients with Stage III prostate cancer in mass screening group considering the effect of lead-time bias.
CONCLUSIONS: Early detection and longer survival of the patients with prostate cancer detected by mass screening suggested the effectiveness of prostate cancer screening.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870805     DOI: 10.1002/pros.10057

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  6 in total

1.  Epidemiological and clinical investigations among employees in a former herbicide production process.

Authors:  Michael Nasterlack; Gerhard Hoffmann; Peter Messerer; Marvin Gerald Ott; Dirk Pallapies; Marcus Wrede; Andreas Zober
Journal:  Int Arch Occup Environ Health       Date:  2006-07-13       Impact factor: 3.015

Review 2.  Prostate cancer in Asian men.

Authors:  Kazuto Ito
Journal:  Nat Rev Urol       Date:  2014-03-04       Impact factor: 14.432

3.  Prostate cancer detection by prostate-specific antigen-based screening in the Japanese Hiroshima area shows early stage, low-grade, and low rate of cancer-specific death compared with clinical detection.

Authors:  Jun Teishima; Satoshi Maruyama; Hideki Mochizuki; Kiyotaka Oka; Kenichiro Ikeda; Keisuke Goto; Hirotaka Nagamatsu; Keisuke Hieda; Koichi Shoji; Akio Matsubara
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 4.  Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.

Authors:  Yasuhide Kitagawa; Mikio Namiki
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

5.  Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania.

Authors:  Ausvydas Patasius; Agne Krilaviciute; Giedre Smailyte
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

6.  Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan.

Authors:  Yasuhide Kitagawa; Kazuaki Machioka; Hiroshi Yaegashi; Kazufumi Nakashima; Mitsuo Ofude; Kouji Izumi; Satoru Ueno; Yoshifumi Kadono; Hiroyuki Konaka; Atsushi Mizokami; Mikio Namiki
Journal:  Asian J Androl       Date:  2014 Nov-Dec       Impact factor: 3.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.